Charles Schwab
PDSB icon

Charles Schwab’s PDS Biotechnology PDSB Stock Holding History

Charles Schwab’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,278
Closed -$50.7K – 3510
2024
Q3 		$50.7K Hold
13,278
– – ﹤0.01% 3413
2024
Q2 		$38.9K Sell
13,278
-63,925
-83% -$205K ﹤0.01% 3537
2024
Q1 		$306K Hold
77,203
– – ﹤0.01% 3171
2023
Q4 		$384K Hold
77,203
– – ﹤0.01% 3168
2023
Q3 		$390K Hold
77,203
– – ﹤0.01% 3136
2023
Q2 		$388K Buy
77,203
+63,925
+481% +$419K ﹤0.01% 3164
2023
Q1 		$81.7K Hold
13,278
– – ﹤0.01% 3280
2022
Q4 		$175K Buy
+13,278
New +$93.7K ﹤0.01% 3198
2018
Q2 		– Sell
-4,475
Closed -$106K – 3139
2018
Q1 		$106K Sell
4,475
-5
-0.1% -$1.34K ﹤0.01% 3035
2017
Q4 		$840K Buy
4,480
+471
+12% +$94.8K ﹤0.01% 2567
2017
Q3 		$861K Buy
4,009
+245
+7% +$50.7K ﹤0.01% 2544
2017
Q2 		$773K Buy
3,764
+27
+0.7% +$5.32K ﹤0.01% 2548
2017
Q1 		$681K Buy
3,737
+239
+7% +$47.3K ﹤0.01% 2544
2016
Q4 		$875K Buy
3,498
+216
+7% +$49.1K ﹤0.01% 2474
2016
Q3 		$684K Buy
3,282
+1,296
+65% +$257K ﹤0.01% 2513
2016
Q2 		$402K Buy
1,986
+669
+51% +$118K ﹤0.01% 2669
2016
Q1 		$242K Buy
1,317
+23
+2% +$4.11K ﹤0.01% 2837
2015
Q4 		$324K Buy
+1,294
New +$417K ﹤0.01% 2835

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab's PDSB Position: Q4 2024 in Review

Charles Schwab sold out of PDS Biotechnology (PDSB) in Q4 2024, closing a stake of 13,278 shares — an estimated $50.7K sold.

Charles Schwab first reported a position in PDSB in Q4 2015 and held it in 18 quarters. The position peaked at $875K in Q4 2016. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2024.

  • Charles Schwab reported no remaining PDS Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Charles Schwab sold 13,278 PDS Biotechnology shares in Q4 2024, an estimated $50.7K.
  • Charles Schwab first reported a position in PDS Biotechnology in Q4 2015 and held it in 18 quarters.
  • Charles Schwab's PDS Biotechnology position peaked at $875K in Q4 2016.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2024.

Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.